XERS News and Press, Xeris Pharmaceuticals Inc. From 08/20/20

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use (RTU) injectable and infusible drug formulations, today announced that its Board of Directors has promoted John P. Sha...

These Names Are On Analysts’ Lists Of Penny Stocks Right Now; Are They On Yours? Penny stocks aren’t just “short-term” movers or “lotto trades” as some might assume. If you’ve been a reader of our articles this year, you have come to learn tha...

Image source: The Motley Fool. Xeris Pharmaceuticals, Inc.   (NASDAQ: XERS) Q2 2020 Earnings Call Aug 10, 2020 , 8:30 a.m. ET Operator Continue reading

Xeris Pharmaceuticals, Inc. (XERS) Q2 2020 Earnings Conference Call August 10, 2020 08:30 a.m. ET Company Representatives Paul Edick - Chairman, Chief Executive Officer Barry Deutsch - Chief Financial Officer Allison Wey - Senior Vice President of Investor Relations & Corpora...

Penny Stock News Has These 4 Names Trending This Week When it comes to penny stocks , the news is easily one of the top catalysts to look for. Key developments are important for investors to pay attention to, obviously. Aside from the initial headlines, you’ll also want to actually rea...

Xeris Pharmaceuticals (NASDAQ: XERS ) : Q2 GAAP EPS of -$0.63 beats by $0.09 . Revenue of $1.98M beats by $0.12M . Shares +10% PM. Press Release More news on: Xeris Pharmaceuticals, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, ,

Gvoke® net sales were $2.0 million in Q2 2020 Gvoke PFS prescriptions grew 72% quarter over quarter July availability of Gvoke HypoPen ™ accelerates prescription growth June capital raise significantly strengthens balance sheet Company to host a conference c...

Looking For Volatile Penny Stocks? 4 To Take A Look At Before Friday Here you are, looking for penny stocks to buy . What do you look at first? Some choose news, others choose technical indicators or chart patterns. Whichever side you fall on, the one thing traders look for in all penny stoc...

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that the Company will release its second quarter 2020 fina...

  XP-0863 Phase 1b results and regulatory feedback support direct to Phase 3 registration study in both pediatric and adult patients with epilepsy Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and...